[1-(3-Methoxyphenyl)-2-propyl]amine en es it fr

Category

[1-(3-Methoxyphenyl)-2-propyl]amine
add to favotites goo dig stu tec squ mys
fac del pro twi yah mya far


[1-(3-Methoxyphenyl)-2-propyl]amine Brand names, [1-(3-Methoxyphenyl)-2-propyl]amine Analogs

[1-(3-Methoxyphenyl)-2-propyl]amine Brand Names Mixture

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)

[1-(3-Methoxyphenyl)-2-propyl]amine Chemical_Formula

C9H13N

[1-(3-Methoxyphenyl)-2-propyl]amine RX_link

http://www.rxlist.com/cgi/generic3/adderallxr.htm

[1-(3-Methoxyphenyl)-2-propyl]amine fda sheet

[1-(3-Methoxyphenyl)-2-propyl]amine msds (material safety sheet)

[1-(3-Methoxyphenyl)-2-propyl]amine Synthesis Reference

U. S. Pat. 1,879,003, (1932)

[1-(3-Methoxyphenyl)-2-propyl]amine Molecular Weight

135.206 g/mol

[1-(3-Methoxyphenyl)-2-propyl]amine Melting Point

Volatizes slowly at room temperature

[1-(3-Methoxyphenyl)-2-propyl]amine H2O Solubility

Slightly

[1-(3-Methoxyphenyl)-2-propyl]amine State

Solid

[1-(3-Methoxyphenyl)-2-propyl]amine LogP

1.799

[1-(3-Methoxyphenyl)-2-propyl]amine Dosage Forms

Capsules

[1-(3-Methoxyphenyl)-2-propyl]amine Indication

For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.

[1-(3-Methoxyphenyl)-2-propyl]amine Pharmacology

Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.

[1-(3-Methoxyphenyl)-2-propyl]amine Absorption

It forms easily absorbed molecules that are highly lipid soluble

[1-(3-Methoxyphenyl)-2-propyl]amine side effects and Toxicity

LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.

[1-(3-Methoxyphenyl)-2-propyl]amine Patient Information

Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

[1-(3-Methoxyphenyl)-2-propyl]amine Organisms Affected

Humans and other mammals